Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial
Carboplatin did not significantly increase EFS but significantly increased the OS in patients with TNBC, with benefits confined to premenopausal patients.
Authors
- Pallavi Parab (ORCID: https://orcid.org/0009-0005-3104-8079)
- Meenakshi Thakur (ORCID: https://orcid.org/0000-0002-1599-9449)
- Sangeeta Desai (ORCID: https://orcid.org/0000-0002-3588-9888)
- Vani Parmar (ORCID: https://orcid.org/0000-0001-6668-6808)
- Palak Popat (ORCID: https://orcid.org/0000-0002-6495-0721)
- Rajiv Sarin (ORCID: https://orcid.org/0000-0002-6405-8282)
- Garvit Chitkara (ORCID: https://orcid.org/0000-0001-8899-1061)
- Tejal Panhale
- Rajendra Badwe (ORCID: https://orcid.org/0000-0002-0480-2831)
- Nita Nair (ORCID: https://orcid.org/0000-0001-5481-7292)
- Sudeep Gupta (ORCID: https://orcid.org/0000-0002-6742-6378)
- Shalaka Prakash Joshi (ORCID: https://orcid.org/0000-0003-3813-4680)
- Vaibhav Vanmali (ORCID: https://orcid.org/0000-0002-3369-1309)
- Rohini Hawaldar (ORCID: https://orcid.org/0000-0002-3114-5689)
- Tanuja M. Shet (ORCID: https://orcid.org/0000-0001-9294-9704)
- Jaya Ghosh (ORCID: https://orcid.org/0000-0001-6670-1772)
- Asawari J. Patil (ORCID: https://orcid.org/0000-0002-8203-986X)
- Tabassum Wadasadawala (ORCID: https://orcid.org/0000-0003-2167-420X)
- Jyoti Bajpai (ORCID: https://orcid.org/0000-0001-7657-3460)
- Rima Pathak (ORCID: https://orcid.org/0000-0002-4887-7130)
- Seema Gulia (ORCID: https://orcid.org/0000-0001-5871-7395)
- Sushmita Rath (ORCID: https://orcid.org/0000-0002-9931-4338)
Institutions
- Homi Bhabha National Institute (IN)
- Tata Memorial Hospital (IN)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-10-20
- DOI
- https://doi.org/10.1200/jco-25-01023
- Citations
- 3
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.81